PTPRM and ovarian carcinoma: The relationship between the expression of PTPRM and the survival prognosis of ovarian cancer patients was analyzed using the GEPIA database, and it was found that the overall survival(OS) of the PTPRM high-expression group was higher than that of the PTPRM low-expression group, and the difference was statistically significant (P < 0.05).